相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden
Filippo Pietrantonio et al.
ONCOLOGIST (2020)
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurelien Marabelle et al.
LANCET ONCOLOGY (2020)
A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies
Andrea Degasperi et al.
NATURE CANCER (2020)
Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis
Steve Lu et al.
JAMA ONCOLOGY (2019)
Malignant sweat gland tumours: an update
Jose C. Cardoso et al.
HISTOPATHOLOGY (2015)
Management of metastatic apocrine hidradenocarcinoma with chemotherapy and radiation
Daniel H. Miller et al.
RARE TUMORS (2015)
Sunitinib efficacy in the treatment of metastatic skin adnexal carcinomas: report of two patients with hidradenocarcinoma and trichoblastic carcinoma
M. Battistella et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Cutaneous Hidradenocarcinoma: A Clinicopathological, Immunohistochemical, and Molecular Biologic Study of 14 Cases, Including Her2/neu Gene Expression/Amplification, TP53 Gene Mutation Analysis, and t(11;19) Translocation
Dmitry V. Kazakov et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2009)
分享论文
